Prenetics Global Limited

NasdaqGM PRE

Prenetics Global Limited Operating Income Margin for the year ending December 31, 2023: -238.73%

Prenetics Global Limited Operating Income Margin is -238.73% for the year ending December 31, 2023, a -417.39% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Prenetics Global Limited Operating Income Margin for the year ending December 31, 2022 was 75.22%, a 2,104.98% change year over year.
  • Prenetics Global Limited Operating Income Margin for the year ending December 31, 2021 was -3.75%, a -352.74% change year over year.
  • Prenetics Global Limited Operating Income Margin for the year ending December 31, 2020 was 1.48%, a 100.75% change year over year.
  • Prenetics Global Limited Operating Income Margin for the year ending December 31, 2019 was -197.44%.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
NasdaqGM: PRE

Prenetics Global Limited

CEO Mr. Sheng Wu Yeung
IPO Date July 16, 2021
Location Hong Kong
Headquarters Unit 701-706, K11 Atelier King’s Road
Employees 320
Sector Healthcare
Industries
Description

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Similar companies

QGEN

Qiagen N.V.

USD 44.64

0.29%

XGN

Exagen Inc.

USD 4.00

-2.44%

SERA

Sera Prognostics, Inc.

USD 6.47

-2.71%

BNR

Burning Rock Biotech Limited

USD 6.68

-1.47%

FONR

FONAR Corporation

USD 15.75

-0.51%

ACRS

Aclaris Therapeutics, Inc.

USD 2.48

3.77%

NEOG

Neogen Corporation

USD 11.46

-0.17%

NOTV

Inotiv, Inc.

USD 4.28

-4.04%

MDXH

MDxHealth SA

USD 1.91

0.00%

CSTL

Castle Biosciences, Inc.

USD 28.27

0.18%

StockViz Staff

February 4, 2025

Any question? Send us an email